Domestic Recreational
The core of Avant's business, with premium flower, pre-rolls and infused pre-rolls sold under BLK MKT™, Tenzo™, Treehugger™ and Flowr™ across major Canadian provincial markets.
Why Avant
Premium Market Leadership
BLK MKT™ ranked #1 in Ontario's premium flower category by sales dollars in Q2 2026, reinforcing Avant's position at the premium end of the market.
Growing Recreational Business
Recreational revenue increased 34% year-to-date in Fiscal 2026, supported by high-performing SKUs and continued portfolio optimization.
Scalable Cultivation Platform
Avant has 15,240 kg of licensed annual production capacity across purpose-built indoor cultivation facilities designed to support premium cannabis production.
Strengthened Balance Sheet
Avant has eliminated nearly 90% of its total outstanding interest-bearing debt in under 24 months, leaving approximately $1 million outstanding as of Q2 2026.
Proven Revenue Growth
Annual gross sales grew from $22.6 million in Fiscal 2022 to $41.3 million in Fiscal 2025, demonstrating significant multi-year growth.
International Growth Platform
Avant serves established export markets including Israel, Australia and Germany, with export identified as the Company's fastest-growing sales channel.
OTCQX: AVTBF | FRA: 1BU0
As of May 31, 2026
Please refer to our Management’s Discussion and Analysis dated July 15, 2026.
At a glance
Market opportunity
The core of Avant's business, with premium flower, pre-rolls and infused pre-rolls sold under BLK MKT™, Tenzo™, Treehugger™ and Flowr™ across major Canadian provincial markets.
Avant's fastest-growing sales channel, serving established international markets including Israel, Australia and Germany, with further opportunities for global expansion.
Premium bulk cannabis supplied to Canadian licensed producers, leveraging Avant's reputation for high-quality flower to compete in the domestic B2B market.
Avant Medical provides qualified patients across Canada with direct access to premium cannabis through its online platform and licensed partners.
Track record
F2022
$22.6M
F2023
$30.2M
F2024
$40.0M
F2025
$41.3M
Annual gross sales. See Annual Audited Financial Statements dated March 2, 2026.
On the Globe & Mail's 2025 list of Canada's Top Growing Companies.
Top 25 undervalued small-micro-nano stocks listed on the TSX (valuation methodology provided by Stockcalc 2024).
blk mkt™, AdCann 2022. Best Rosin, KIND Awards 2022, plus multiple KIND and AdCann finalist placements.
News
Stay informed
Stay close to the story as the Company grows. Receive news releases, financial results and corporate milestones the moment they are announced.
Forward-Looking Statements
This website contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements reflect management's current expectations, estimates and projections and involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. Readers should not place undue reliance on forward-looking statements. Avant Brands Inc. undertakes no obligation to update or revise any forward-looking information except as required by law. For additional information regarding the risks associated with Avant Brands, please refer to the Company's most recent Annual Information Form and MD&A filed on SEDAR+.